Accueil > Revues > Médecine > European Journal of Dermatology > Texte intégral de l'article
 
      Recherche avancée    Panier    English version 
 
Nouveautés
Catalogue/Recherche
Collections
Toutes les revues
Médecine
European Journal of Dermatology
- Numéro en cours
- Archives
- S'abonner
- Commander un       numéro
- Plus d'infos
Biologie et recherche
Santé publique
Agronomie et Biotech.
Mon compte
Mot de passe oublié ?
Activer mon compte
S'abonner
Licences IP
- Mode d'emploi
- Demande de devis
- Contrat de licence
Commander un numéro
Articles à la carte
Newsletters
Publier chez JLE
Revues
Ouvrages
Espace annonceurs
Droits étrangers
Diffuseurs



 

Texte intégral de l'article
 
  Version imprimable

Mitogen requirements of normal epidermal human melanocytes in a serum and tumor promoter free medium


European Journal of Dermatology. Volume 13, Numéro 1, 29-33, January - February 2003, Rapports d'investigature


Summary  

Auteur(s) : M.B. ABDEL-NASER, Dept. of Dermatology and Venereology, Ain Shams Uni. Hospital, Cairo, Egypt.

Illustrations

ARTICLE

Normal human melanocyte (NHM) grows poorly in culture unless stimulated by serum and several other mitogens. In 1982, Eisinger and Marko successfully isolated pure NHM in a medium that has been supplemented with 5 % fetal bovine serum, the tumor promoter 12-O-tetradecanoylphorbol 13-acetate (TPA) and cholera toxin [1]. Likewise, Tsuji and Karasek obtained NHM in a medium containing, in addition to 10 % fetal calf serum, cholera toxin, cAMP elevator and 5-fluorouracil [2]. The elimination of keratinocytes from these cultures has been attributed to the toxic effects of TPA and the cytotoxic drug. Nevertheless, because of the high concentration of serum, fibroblasts were still a major contaminant [3]. Furthermore, another major disadvantage of both culture models was the use of serum and potentially mutagenic agents that render cells obtained inappropriate for either research or therapy [4]. Gilchrest et al. overcame this problem and successfully isolated NHM in a hormone-supplemented medium that had been enriched with minimal serum supplementation [5]. Nevertheless, keratinocyte and fibroblast elimination and the low yield of NHM were also obvious problems in this culture system [3, 5].

This report describes a modification of this culture system, which completely avoids the problem of keratinocyte and fibroblast contamination and supports good melanocyte proliferation in the absence of tumor precursors and without serum supplementation. In addition, the relative significance of each mitogen on melanocyte proliferation has been examined.

Material and methods

Melanocyte culture and morphological characteristics

Melanocyte culture was obtained from newborn foreskin and adult truncal skin, obtained from adults undergoing elective operations (3 different donors each, type IV skin). Specimens were transported to the laboratory in tissue culture medium. The steps of skin processing and obtaining cell suspensions were followed as previously described [5, 6]. Briefly, deep dermis and subcutaneous fat are cut short (to minimize the risk of contaminating melanocyte cultures with fibroblasts), remaining skin is cut into 4-5 mm3 pieces and incubated in 0.25 % trypsin (Sigma, Deisenhofen, Germany) for 16 h at 4 °C. During this time, separation of the epidermis from the dermis is observed. Fetal calf serum (FCS) (10 %) (Biochrom, Berlin, Germany) is added to the specimens to inactivate the trypsin and separation of the epidermis from the dermis is completed with the aid of forceps. The dermis is discarded whereas the epidermis is vigorously pipetted to obtain a single cell suspension. The epidermal cells are counted in a hemocytometer chamber and inoculated at a density of 1.25 x 105 cells/ml in melanocyte growth medium (MGM) and maintained in 8 % CO2 and 92 % air. The medium is changed 2-3 times weekly. The complete MGM consisted of modified MCDB 153 (MCDB 153 + amino acids + antibiotics) (Biochrom), cholera toxin (10 — 9 M) (Calbiochem, Bad Soden, Gemany), basic fibroblast growth factor (bFGF) (2 ng/ml) (Boehringer, Mannheim, Germany), epidermal growth factor (EGF) (10 ng/ml), crude bovine pituitary extract (BPE) (70 mu g/ml) (Clonetics, San Diego, CA, USA), calcium hydrochloride (2 mM) (Merck, Darmstadt, Germany), insulin (10 >mu g/ml), transferrin (10 mu g/ml) (Sigma, Deisenhofen, Germany), hydrocortisone (1.4 x 10 — 6 M) (Serva, Heidelberg, Germany) and triiodothyronine(10 — 9 M) (Sigma). FCS (2 %) was added only during the first 2 days of the primary culture and the first 24 hours of each subculture. Cells (6-well culture plate) were monitored by inverted phase contrast microscopy (Olympus, Tokoyo, Japan). Photographs were taken to document and monitor microscopic alterations after cultures were washed once with Ca + + and Mg + + free phosphate buffer saline (PBS) (Biochrom).

Proliferation assays

First passage pure NHM cultures were used in this experiment (obtained from each of the 3 newborn foreskins). Proliferation assays of cells were carried out (each in triplicate) in tissue culture plates (96 flat bottomed wells) (Becton and Dickenson, Mountain view, CA) by incubating 1 x 103 cell/well in 0.2 ml of medium by the highly sensitive fluorimetric microassay using 4-methylumbelliferyl heptanoate. Fluorimetric values, expressed as absolute fluorescence units, were measured by a Titertec Fluoroscan II (Flow Lab Meckenheim, Germany) as previously described [7]. Each supplement was omitted from the complete MGM and the proliferation rates were measured one day after inoculation (day 0) and every 3 days afterwards for 3 weeks.

Immunohistochemistry

First passage NHMs from both newborn and adults were labeled with alkaline phosphatase-antialkaline phosphatase (APAAP) technique as previously described [8, 9]. Briefly, cells were fixed with pre-cooled methanol (— 4 °C) for 5 min and were exposed to primary antibody (30 min) diluted in 0.1 M (1:100). As a secondary antibody, anti-mouse IgG (Immunotech, Marsielle, France) diluted in 1:100 in PBS was used with APAAP complex (Dako, Glostrup, Denmark). The incubation steps with the secondary antibody and the APAAP complex were repeated twice (30 min each) to intensify the labeling reaction. Naphthol AS BI sodium salt (Sigma) and new fuchsin (Merck) were used for visualization. Lastly, counterstaining with Meyer’s hemalaun solution (Merck) was done. The slides were mounted with Kaiser’s glycerol gelatin (Merck) and examined by light microscopy. Fixed cells not exposed to the primary antibody served as negative control. Positive staining appears bright red, whereas negative staining acquires the counterstain as a faint blue color.

Statistical analysis

The mean and SD values obtained from the three newborn foreskins (each in triplicate) were calculated and the percentage decrease of proliferation was determined. Student’s t test was used for statistical evaluation and p values of < 0.05 were considered significant.

Results

Melanocyte culture characteristics and morphological features

Microscopic examination of the culture immediately after inoculation of the desegregated epidermal cells revealed rounded refractile cells floating in the medium. However, as early as 12 h of inoculation two populations of cells, namely small dark bipolar and tripolar cells were seen in between flat small rounded and polygonal cells that represent the keratinocytes (Fig. 1). On subsequent days, large sheets of keratinocytes are formed and the number of dendritic cells progressively increased. The presumed dendritic melanocytes were almost always seen in contact with adjacent keratinocytes via their dendrites [5, 10] (Fig. 2). After 3-4 weeks in adult culture and 4-5 weeks in newborn culture, keratinocytes detached from the culture plate and the dendritic cells changed their morphology to bipolar or fibroblasts-like spindle shaped cells reminiscent of histopathological feature of intradermal melanocytic nevus (Fig. 3). By the 5th week, almost all keratinocytes have been detached from the culture plate and only one population of cells remained. The presumed melanocytes could be passaged up to 6 times in newborn and 4 times in adult skin (average 5 weeks), after which cells underwent senescence, became clumped and degenerated regardless of any mitogen, including serum, added to them (Fig. 4). No striking difference between melanocytes of adults and newborns was observed, though newborn NHM were more slender and tended to be less dendritic. Removal of each mitogen did not have any striking effect on melanocyte morphology as cells retained their characteristic fibroblast-like shape that is seen with the complete MGM, though the density of NHM decreased progressively in the absence of mitogens. NHM incubated with plain medium were almost absent from culture plates from day 6 through day 21 of incubation.

Proliferation assays

Proliferation assay in the absence of each mitogen one day after inoculation (day 0) revealed no significant results not only with the complete MGM medium but also with cells incubated with plain medium (p > 0.05). Interestingly, 3 days after incubation, a significant increase of growth of NHM incubated not only with the complete MGM medium but also with the plain and supplement deficient media when compared with day 0 was detected (< 0.001). Absence of cholera toxin, EGF, Ca + +, transferrin, hydro cortisone, and triiodothyronine did not significantly affect NHM proliferation (p > 0.05). However, absence of bFGF, BPE and insulin was associated with a significant NHM growth retardation (p < 0.01). Similarly, NHM incubated with plain medium showed a significant decrease of proliferation (p < 0.001). Six days after incubation revealed similar results, though there was a significant drop of proliferation rate values that reached almost less than 50 % of day 3 (p < 0.001). Proliferation rate of NHM on subsequent days, i.e., 9, 12, 15, 18 and 21 revealed a significant decrease of proliferation in the absence of each mitogen when compared with the complete MGM (p < 0.001) (Table II). From day 12 through day 21, no further significant increase of proliferation rate of the NHM incubated with the complete MGM was detected as the proliferation rate reached to a plateau. Virtually, no NHM proliferation was detected in culture plates incubated with plain medium on day 6 and thereafter (Fig. 5).

Immunohistochemical findings

All cultured cells showed strong positive reaction to MAbs detecting differentiated melanocytes and melanin producing cells, namely HMB 45 and K.1.2.58. No significant number of cells showing negative labeling was detected. The characteristic fibroblast-like morphology was well preserved and could be easily visualized. The cytoplasm of the cells contained fine granules showing the strong labeling, which represents the labeling with the melanosomal antigen targeted by the activation marker HMB-45 [11] (Fig. 6a). Similarly, all cultured cells showed negative reaction to MAbs specific for other epidermal cells, such as basal or suprabasal keratinocytes and Langerhans cells (Fig. 6b). No difference in antigen expression was detected between newborn and adult skin NHM. Similarly, no striking difference in antigens expression was detected in the absence of any mitogen.

Discussion

Serum is a potent growth factor for all cells and melanocytes are no exception. However, because of its presence, the melanocytes obtained may not be optimal for examination of factors that may influence melanocyte function; as serum may contain substances having structural or functional similarities with those being tested and hence their effects could be masked. Also, because of the presence of TPA, a potential carcinogenic agent, melanocytes obtained are not suitable for therapeutic purposes [4, 12]. Results of the present study show that melanocytes, indeed, can be easily grown in a serum- and TPA- free medium.

Fetal calf serum (2 %) is added to cultures at time of inoculation for 48 hrs in primary culture and with every passage for first 24 hrs only. Addition of serum has been found to be responsible for attachment of the cultivated cells to culture plates and for stimulation of their growth [5]. Although serum was essential for attachment of adult melanocytes, it was not essential for attachment of melanocytes of newborn origin, however, melanocyte yield in the absence of serum was low (20-30 % of the 2 % serum-containing complete MGM medium) (data not shown). Keratinocytes and melanocytes grow usually together, however, after the differentiation, full keratinization and separation, the melanocytes continue to grow and pure melanocyte cultures are obtained. The minor differences of NHM morphology between adults and newborns are most probably due to the relative higher proliferative capacity of the latter.

A constant observation in this study and others is the close relationship of NHM and keratinocytes in which NHMs were almost always seen in contact with the adjacent keratinocyte colonies with dendritic projections. Pure melanocytes in culture were fibroblast like or spindle shaped cells. Removal of each mitogen did not have any striking effect on melanocyte morphology. Indeed, it has been shown that contact with differentiated keratinocytes is the signal for dendrite formation [10, 13]. Although pure melanocytes could be obtained after several weeks, the presence of keratinocytes was of benefit due to the supporting nature and the paracrine stimulatory effects of these cells [10, 14]. This was also the rational for the use of MCD153 medium with added supplements as it supports growth of both melanocytes and keratinocytes but is suboptimal for fibroblasts [15]. Although alpha-melanocyte stimulating hormone can replace some of the added mitogens e.g., BPE, it was not used in the present work as it is not known to support keratinocyte proliferation [16]. Calcium is usually added to medium to induce keratinocyte differentiation and keratinization rather than as a mitogen [17].

Proliferation assay in the absence of each mitogen revealed significant results that could be detected as early as 3 days of incubation. The initial increase of proliferation that was observed is most likely due to the effect of serum that has been removed on day 0 of assessment. In favor of this assumption is the drastic drop of proliferation on day 6; by that time the effect of serum has disappeared. Nevertheless, absence of bFGF, insulin and BPE resulted in a significant decreased NHM proliferation that was also observed on day 6. As most experimental or therapeutic works are done within one week of NHM passage, it is evident that they are the most significant mitogens [18-20]. Absence of all added supplements revealed significant NHM growth retardation from day 9 and afterwards, indicating that long term NHM cultures require several mitogens for survival and proliferation. It has been shown that confluence or growth factors depletion caused reversible, G1 phase-specific, NHM cycle growth arrest; thus providing an explanation for the almost non significant change in NHM proliferation from day 9 through day 21 of incubation [20]. The main mitogenic component in BPE is bFGF [21]; results of the present work, however, indicate that factors in pituitary extract other than bFGF are also essential for melanocyte proliferation, alpha MSH is a possible candidate [12].

The identity of the melanocytes is confirmed by the positive labeling with specific MAbs. NHMs in culture but not in situ express melanoma associated antigens. Nevertheless, this phenomenon does not reflect the genetic and biologic properties, since the cultured NHMs have a diploid karyotype, are non-tumorigenic and do not spontaneously transform in culture [22]. The almost complete absence of other epidermal and dermal cells as shown immunohistochemically is a clear advantage of this culture system.

From the above data, it is obvious that NHM can be selectively cultivated in a serum free medium and without the use of tumor promoters. It is also concluded that bFGF, insulin and BPE are of marked significance for melanocyte growth from the early phases of pure melanocyte culture, whereas the other supplements, although stimulating melanocyte proliferation, are not essential. It is also recommended that examining factors that may influence melanocyte proliferation should be carried out in the absence of all or any of these mitogens according to experimental design.

CONCLUSION

Article accepted on 2/12/2002

REFERENCES

1
Eisinger M, Marko O. Selective proliferation of normal human melanocytes in vitro in the presence of phorbol ester and cholera toxin. Proc Natl Acad Sci USA 1982; 79: 2018-22.

2
Tsuji T, Karasek M. A procedure for isolation of primary cultures of melanocytes from newborn and adult human skin. J Invest Dermatol 1983; 81: 179-80.

3
Horikawa T, Norris DA, Zekman T, Morelli JG. Effective elimination of fibroblats in cultures of melanocytes by lowering calcium concentration in TPA depleted medium following geneticin treatment. Pigment Cell Res 1996; 9: 58-62.

4
Lerner AB, Halaban R, Klaus SN, et al. Transplantation of human melanocytes. J Invest Dermatol 1987; 89: 219-24.

5
Gilchrest BA, Vrabel MA, Flynn E, Szabo G. Selective cultivation of human melanocytes from newborn and adult epidermis. J Invest Dermatol 1984; 83: 370-6.

6
Abdel-Nasser MB, Hann S-K, Bystryn J-C. Oral psoralen with UV — A therapy releases circulation growth factor(s) that stimulate cell proliferation. Arch Dermatol 1997; 133: 1530-3.

7
Stadler R, Detmar M, Stephanek K, et al. A rapid flurometric assay for the determination of keratinocyte proliferation in vitro. J Invest Dermatol 1989; 93: 532-34s.

8
Cordell JL, Falini B, Erber WN, et al. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal antialkaline phosphatase (APAA P complex). J Histochem Cytochem 1984; 32: 219-29.

9
Krasagakis K, Garbe C, Kruger S, Orfanos CE. Effects of interferons on cultured human melanocytes in vitro: Interferon-beta but not alpha or gamma inhibit proliferation and all interferons significantly modulate the cell phenotype. J Invest Dermatol 1991; 97: 364-72.

10
Abdel Naser MB. Differential effects on melanocyte growth and melanization of low vs high calcium keratinocyte conditioned medium. Brit J Dermatol 1999; 140: 50-5.

11
Ooka S, Kawa Y, Ito M, et al. Establishment and characterization of a mouse derived neural crest derived cell line (Nccmela5). Pigment Cell Res 2001; 14: 268-74.

12
Swope VB, Medrano EE, Salmara D, Abdel Malek Z. Long term proliferation of human melanocytes is supported by the physiologic mitogens alpha-melanotropin, endothelin-1 and basic fibroblast growth factor. Exp Cell Res 1995; 27: 453-9.

13
Gordon PR, Mansur CP, Gilchrest BA. Regulation of human melanocyte growth, dendricity and melanization by keratinocyte derived factors. J Invest Dermatol 1989; 92: 565-72.

14
Halaban R, Langdon R, Birchall N, et al. Basic fibroblast growth factor from human keratinocytes is a natural mitogen for melanocytes. J Cell Biol 1988; 107: 1611-9.

15
Mc Keehan WL, Mc Keehan RA. Calcium, Magnesium, and serum factors in multiplication of normal and transformed human lung fibroblasts. In vitro 1980; 16: 475-85.

16
Tsatmali M, Ancans J, Thody AJ. Melanocyte function and its control by melanocortin peptides. J Histochem Cytochem 2002; 50: 125-33.

17
Daniels JT, Harris IR, Kearney JN, Ingham E. Calcium: A crucial consideration in serum-free keratinocyte culture. Exp Dermatol 1995; 4: 183-91.

18
Herlyn M, Mancianti ML, Jambrosic J, et al. Regulatory factors that determine growth and phenotype of normal human melanocytes. Exp Cell Res 1988; 179: 322-31.

19
Eisinger M, Marko O, Ogata S, Old LJ. Growth regulation of human melanocyte mitogenic factors in extracts of melanoma, astrocytoma and fibroblast cell lines. Science 1985; 229: 984-6.

20
Pittelkow MR, Shipley GD. Serum free culture of normal human melanocytes: Growth kinetics and growth factor requirements. J Cell Physiol 1989; 140: 565-76.

21
Halaban R, Ghosh S, Baird A. bFGF is the putative natural growth factor for human melanocytes. In Vitro Cell Dev Biol 1987; 23: 47-52.

22
Herlyn M, Thurin J, Balaban G, et al. Characteristics of cultured human melanocytes isolated from different stages of tumor progression. Cancer Res 1985; 45: 5670-6.


 

Qui sommes-nous ? - Contactez-nous - Conditions d'utilisation - Paiement sécurisé
Actualités - Les congrès
Copyright © 2007 John Libbey Eurotext - Tous droits réservés
[ Informations légales - Powered by Dolomède ]